CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices
U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of… Read More

U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of… Read More
Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name… Read More
White House Should Reject Pharma-Backed Policies That Would Hand Drug… Read More
Encourages Administration to Reject Measure That Would Increase Premiums on… Read More
Administration Should Withdraw Big Pharma-Backed Policies Like the Rebate… Read More
Administration Should Abandon Previously Rejected Measure That Rewards Drug… Read More
Drug Companies Begin Summer Price Increases With Hikes On 42 Brand Name Drugs… Read More
Survey Finds 83 Percent of Americans Believe Drug Companies Should Stop Price… Read More
New Poll Underscores Need for Big Pharma to Suspend Summer Price Hikes and for… Read More
Lawmakers Must Step-in to Enact DTC List Price Disclosures, Additional… Read More
Drug Companies Must Forgo Mid-Year Price Increases While Millions of Americans… Read More
Coalition Applauds Positive Step from the Administration to Lower Insulin… Read More